Locate Bio
Locate is based in MediCity and has developed a family of unique, thermally-activated, injectable scaffolds that solidify within the body and can be used to support tissue growth before degrading away.

Profile
The TAOSTM (Targeted, Orchestrated Signalling) technology is a world first in tissue repair and enables the precision focus of therapeutic signals from small molecule or biological actives at the site of repair. TAOSTM has many potential application sites across the body.
Pipeline technology includes RPMax, a thermo-reversible matrix, and IntraStem, a new delivery system for cells; technologies that can meet industry recognised needs to advance cell therapy markets such as transfection, genome editing and induced pluripotent stem cells.
News and press releases
Data privacy startup ID Ward raises €1.1 million to launch its decentralised advertising technology
- 2nd February 2022 11:53 am·
NuVision Biotherapies announces the appointment of its new Chief Executive Officer and Chief Operating Officer
- 13th January 2022 11:43 am·
BlueSkeye AI shortlisted as a finalist for the Medilink Midlands Business Awards 2022
- 17th December 2021 12:40 pm·
University spin-out named best medtech start-up
- 29th November 2021 2:47 pm·
Green jobs at Cheesecake Energy
- 1st November 2021 4:07 pm·
Steve Cliffe joins BlueSkeye AI as it scales the development of its technology and customer portfolio
- 26th October 2021 9:36 am·
Cheesecake Energy announces new board appointments
- 5th October 2021 4:05 pm·
Cheesecake Energy secures £1m seed investment
- 28th September 2021 4:09 pm·
New University spin out to deliver faster and safer engineering maintenance technologies
- 23rd September 2021 1:44 pm·
Locate Bio Closes £10 million Funding Round
- 3rd September 2021 1:33 pm·
Spin-out company launched to deliver wrist device to control Tourette’s
- 9th August 2021 1:03 pm·
Biotech firm that ‘could revolutionise woundcare’ raises £1.8m
- 19th July 2021 3:23 pm·
TextureJet plays a key role in enabling UK manufacturing to Build Back Better
- 1st July 2021 10:12 am·

@locatebio on Twitter
@Locate Bio is attending @Phacilitate's Advanced Therapies Week conference in Miami this week, after being named as one of their Top 20 companies to watch. #CellTherapy #GeneTherapy
@LocateBio senior management will be available for investor and partnering meetings at the #biotechshowcase in San Francisco, 13-15 January 2020.
@LocateBio named one of the Top 20 Advanced Therapy biotechs to watch in 2020, curated with input from industry nominations and @Phacilitate. https://www.phacilitate.co.uk/article/top-20-advanced-therapy-biotechs-watch-2020
@LocateBio CEO Nick Staples and CFO/COO John von Benecke will be attending the LSX #Investival and #Jefferies 2019 Healthcare conferences in London on the 19 and 20-21 November respectively. They will be available for partnering and investor meetings.
@LocateBio CEO Nick Staples and CFO John von Benecke are attending #BIOEurope conference in Hamburg, November 11-13 and will be available for partnering and investor meetings
@LocateBio appoints John von Benecke as CFO and COO, and to the Board of Directors. He has raised more than $130m of venture capital to date and taken two start-ups through to successful exit events. http://bit.ly/LocateCFO
@LocateBio will be attending #BioEquity in Barcelona on 20-21 May and #BIO2019 in Philadelphia on 3-6 June. CEO Nick Staples will be available for investor and partnering meetings.
@LocateBio receives £2million of new investment to advance #IntraStem its non-viral gene therapy technology and #TAOS cell delivery platform, and expand its in-house cell and gene therapy pipeline. £1.8million was a direct investment from @MerciaTech and £0.2m from MEIF.